| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GLT1D1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | C15orf65 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | FECH | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | XRN2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | HEXB | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | KMT2D | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | WNK2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | LONRF2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | PDCD2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
